These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 12883495

  • 1. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
    McCaffrey AP, Meuse L, Karimi M, Contag CH, Kay MA.
    Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
    [Abstract] [Full Text] [Related]

  • 2. Involvement of proteasome alpha-subunit PSMA7 in hepatitis C virus internal ribosome entry site-mediated translation.
    Krüger M, Beger C, Welch PJ, Barber JR, Manns MP, Wong-Staal F.
    Mol Cell Biol; 2001 Dec; 21(24):8357-64. PubMed ID: 11713272
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
    Alotte C, Martin A, Caldarelli SA, Di Giorgio A, Condom R, Zoulim F, Durantel D, Hantz O.
    Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
    [Abstract] [Full Text] [Related]

  • 9. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
    Soler M, McHutchison JG, Kwoh TJ, Dorr FA, Pawlotsky JM.
    Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
    [Abstract] [Full Text] [Related]

  • 10. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses.
    Dasgupta A, Das S, Izumi R, Venkatesan A, Barat B.
    FEMS Microbiol Lett; 2004 May 15; 234(2):189-99. PubMed ID: 15135522
    [Abstract] [Full Text] [Related]

  • 11. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
    Pudi R, Ramamurthy SS, Das S.
    J Virol; 2005 Aug 15; 79(15):9842-53. PubMed ID: 16014945
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
    Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH.
    Hepatology; 1995 Sep 15; 22(3):707-17. PubMed ID: 7657273
    [Abstract] [Full Text] [Related]

  • 14. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
    Wang H, Shen XT, Ye R, Lan SY, Xiang L, Yuan ZH.
    Arch Virol; 2005 Jun 15; 150(6):1085-99. PubMed ID: 15747050
    [Abstract] [Full Text] [Related]

  • 15. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
    Wakita T, Moradpour D, Tokushihge K, Wands JR.
    J Med Virol; 1999 Mar 15; 57(3):217-22. PubMed ID: 10022790
    [Abstract] [Full Text] [Related]

  • 16. RNA-binding protein hnRNP D modulates internal ribosome entry site-dependent translation of hepatitis C virus RNA.
    Paek KY, Kim CS, Park SM, Kim JH, Jang SK.
    J Virol; 2008 Dec 15; 82(24):12082-93. PubMed ID: 18842733
    [Abstract] [Full Text] [Related]

  • 17. Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation.
    Tallet-Lopez B, Aldaz-Carroll L, Chabas S, Dausse E, Staedel C, Toulmé JJ.
    Nucleic Acids Res; 2003 Jan 15; 31(2):734-42. PubMed ID: 12527783
    [Abstract] [Full Text] [Related]

  • 18. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S, Prabhu R, Hazari S, Bastian F, Garry R, Zou W, Haque S, Joshi V, Regenstein FG, Thung SN.
    Liver Int; 2005 Jun 15; 25(3):580-94. PubMed ID: 15910496
    [Abstract] [Full Text] [Related]

  • 19. [Inhibition of HCV IRES controlled reporter gene expression by RNA interference].
    Chen WX, Shan LN, Chen J, Zhang ZZ, Zhang BQ, Huang AL.
    Zhonghua Gan Zang Bing Za Zhi; 2006 Jul 15; 14(7):521-4. PubMed ID: 16867275
    [Abstract] [Full Text] [Related]

  • 20. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice.
    McCaffrey AP, Ohashi K, Meuse L, Shen S, Lancaster AM, Lukavsky PJ, Sarnow P, Kay MA.
    Mol Ther; 2002 Jun 15; 5(6):676-84. PubMed ID: 12027551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.